Please login to the form below

Not currently logged in
Email:
Password:

Sun Pharmaceutical Industries

This page shows the latest Sun Pharmaceutical Industries news and features for those working in and with pharma, biotech and healthcare.

Merck and Sun Pharma part company on branded generics

Merck and Sun Pharma part company on branded generics

Will continue partnership on diabetes and inflammatory disorder projects. Merck &Co and India's Sun Pharmaceutical Industries have agreed to dissolve a joint venture set up in 2011 to develop and ... Sun acquired global rights to tildrakizumab (MK-3222)

Latest news

  • Sun Pharma recalls antidepressant in US Sun Pharma recalls antidepressant in US

    Withdraws more than 40, 000 bottles of venlafaxine hydrochloride. India-based Sun Pharmaceutical Industries is to recall more than 40, 000 bottles of an antidepressant after the drug was discovered to ... This is the latest in a series of setbacks for

  • Pfizer sales dip as net income surges in Q2 Pfizer sales dip as net income surges in Q2

    from the spin-out of Zoetis and a litigation settlement with Teva and Sun Pharmaceutical Industries for patent infringement of Protonix (pantoprazole) fell 5 per cent.

  • MSD forms joint venture with Sun Pharma

    MSD (known as Merck in the US and Canada) has entered into a joint venture with India's Sun Pharmaceutical Industries to develop, manufacture and commercialise new combinations and formulations of ... The company has a proven track record in innovative

  • Thin on the ground

    Rheumatoid arthritis. Europe. Rivastigmine. Watson Pharmaceuticals. Dementia. US. Rivastigmine. Sun Pharmaceutical Industries. ... Lysteda (Ferring Pharmaceuticals). Cyclic heavy menstrual bleeding. US. Venlafaxine. Teva Pharmaceutical Industries.

  • Taro shareholders' meeting postponed

    US-headquartered Taro Pharmaceutical Industries has postponed its proposed shareholder meeting on 25 September, which was to discuss the proposed merger with India's Sun Pharmaceutical Industries. ... India's largest pharmaceutical company, Sun

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest Intelligence

  • Pharma deals during April 2014 Pharma deals during April 2014

    April also saw Sun Pharmaceutical Industries relieving Daiichi Sankyo (63.9% owner) of the troubled Ranbaxy Laboratories to create India's largest pharma company, leading in 13 speciality segments, with estimated ... is rumoured that a solution will be

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics